Federal contract award
75N92E24P00283
GOLDEN HELIX SEQUENCE ANALYSIS SOFTWARE ALLOWS FOR LARGE-SCALE ANALYSIS OF EXOME AND GENOME DATA. THIS ALLOWS OUR LAB TO PARTICIPATE IN THE CLINICAL GENOMICS PROGRAM OF NHGRI LED BY DR. BIESECKER AND TO HAVE THE ABILITY TO SHARE INDIVIDUAL INVESTIGA
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NHGRI |
| NAICS | 513210 — Software Publishers |
| PSC | 7A20 — Application development software delivered by perpetual license, consisting of analysis, design, development, code, test and release packages associated with application development projects. |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $24.0K |
| Current contract value | $24.0K |
| Potential contract value / ceiling | $24.0K |
| Start date | Aug 26, 2024 |
| Current end date | Mar 31, 2025 |
| Potential end date | Mar 31, 2025 |
| Latest award activity | Apr 4, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 4, 2025 | P00002 | $0 | GOLDEN HELIX SEQUENCE ANALYSIS SOFTWARE ALLOWS FOR LARGE-SCALE ANALYSIS OF EXOME AND GENOME DATA. THIS ALLOWS OUR LAB TO PARTICIPATE IN THE CLINICAL GENOMICS PROGRAM OF NHGRI LED BY DR. BIESECKER AND TO HAVE THE ABILITY TO SHARE INDIVIDUAL INVESTIGA |
| Apr 1, 2025 | P00001 | $0 | GOLDEN HELIX SEQUENCE ANALYSIS SOFTWARE ALLOWS FOR LARGE-SCALE ANALYSIS OF EXOME AND GENOME DATA. THIS ALLOWS OUR LAB TO PARTICIPATE IN THE CLINICAL GENOMICS PROGRAM OF NHGRI LED BY DR. BIESECKER AND TO HAVE THE ABILITY TO SHARE INDIVIDUAL INVESTIGA |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.